Olfaction in neurodegenerative disease: A meta-analysis of olfactory functioning in Ahlzheimer's and Parkinson's diseases

Archives of Neurology

Volumn 55, Issue 1, 1998, Pages 84-90

  Mesholam, Raquelle I ^a,b,c   Moberg, Paul J ^b   Mahr, Richard N ^b   Doty, Richard L ^c  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Brain Behavior Laboratory   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DEGENERATIVE DISEASE; HUMAN; META ANALYSIS; OLFACTORY DISCRIMINATION; PARKINSON DISEASE; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; SMELLING; SMELLING DISORDER;

ADULT; AGED; ALZHEIMER DISEASE; EFFECT MODIFIERS (EPIDEMIOLOGY); FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; SMELL;

EID: 0031886320     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.1.84     Document Type: Article

References (76)

1. Richard J, Bizzini L. Olfaction et démences: premiers resultats d'une étude clinique et experimentale avec le N-propanol. Acta Neurol Belg. 1981;81:333-351.
2. Ansari KA, Johnson A. Olfactory function in patients with Parkinson's disease. J Chronic Dis. 1975;28:497.
3. Doty RL, Reyes PF, Gregor T. Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Res Bull. 1987;18:597-600.
4. Serby M, Corwin J, Conrad P, Rotrosen J. Olfactory dysfunction in Alzheimer's disease and Parkinson's disease. Am J Psychiatry. 1985;142:781-782.
5. Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1992;55:138-142.
6. Ward CD, Hess WA, Caine DB. Olfactory impairment in Parkinson's disease. Neurology. 1983;33:943-946.
7. Moberg PJ, Pearlson GD, Speedie LJ, Lipsey JR, Strauss ME, Folstein SE. Olfactory recognition: differential impairments in early and late Huntington's and Alzheimer's diseases. J Clin Exp Neuropsychol. 1987;9:650-664.
8. Nordin S, Murphy C, Paulsen JS. Sensory- and memory-mediated olfactory dysfunction in Huntington's disease. J Int Neuropsychol Soc. 1995;1:281-290.
9. Jones BP, Moskowitz HR, Butters N, Glosser G. Olfactory discrimination in alcoholic Korsakoft patients. Neuropsychologia. 1975;13:173-179.
10. Mair RG, Doty RL, Kelly KM, et al. Multimodal sensory discrimination deficits in Korsakoff's psychosis. Neuropsychologia. 1986;24:831-839.
11. Doty RL, Peri DP, Steele JC, Chen KM. Odor identification deficit of the parkinsonism-dementia complex of Guam: equivalence to that of Alzheimer's and idiopathic Parkinson's disease. Neurology. 1991;41(suppl 2):77-80.
12. Sajjadian A, Doty RL, Gutnick DM, Shirugi RJ, Sivak M, Perl D. Olfactory dysfunction in amyotrophic lateral sclerosis. Neurodegeneration. 1994;3:1-5.
13. Doty RL. Olfactory dysfunction in neurodegenerative disorders. In: Getchell TV, Doty RL, Bartoshuk LM, Snow JB, eds. Smell and Taste in Health and Disease. New York, NY: Raven Press; 1991:735-751.
14. Knupfer L, Spiegel R. Differences in olfactory test performance between normal aged, Alzheimer and vascular type dementia individuals. Int J Geriatr Psychiatry. 1986;1:3-14.
15. Waldton S. Clinical observations of impaired cranial nerve function in senile dementia. Acta Psychiatr Scand. 1974;50:539-547.
16. Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology. 1988;38:1237-1244.
17. Rosenthal R. Meta-analytic Procedures for Social Research. Beverly Hills, Calif: Sage Publications; 1984.
18. Doty RL, Shaman P, Dann M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav. 1984;32:489-502.
19. Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York, NY: Academic Press; 1977.
20. Glass GV. Integrating findings: the meta-analysis of research. Rev Res Educ. 1977;5:351.
21. Doty RL, Perl DP, Steele JC, et al. Olfactory dysfunction in three neurodegenerative diseases. Geriatrics. 1991;46(suppl 1):47-51.
22. Doty RL, Smith R, McKeown DA, Raj J. Tests of human olfactory function: principal components analysis suggests that most measure a common source of variance. Percept Psychophys. 1994;56:701-707.
23. Eichenbaum H, Morton TH, Potter H, Corkin S. Selective olfactory deficits in case H.M. Brain. 1983;106:459-472.
24. Eskenazi B, Cain WS, Novelly RA, Mattson R. Odor perception in temporal lobe epilepsy patients with and without temporal lobectomy. Neuropsychologia. 1986;24:553-562.
25. Rausch R. Serafetinides: specific alteration of olfaction function in humans with temporal lobe lesions. Nature. 1975;225:557-558.
26. Martinez BA, Cain WS, de Wijk RA, Spencer DD, Novelly RA, Sass KJ. Olfactory functioning before and after temporal lobe resection for intractable seizures. Neuropsychology, 1993;7:351-363.
27. West SE, Doty RL. Influence of epilepsy and temporal lobe resection on olfactory function. Epilesia. 1995;36:531-542.
28. Doty RL, Riklan M, Deems DA, Reynolds C, Stellar S. The olfactory deficits of Parkinson's disease: evidence for independence. Ann Neurol. 1989;25:251-256.
29. Doty RL. Olfactory capacities in aging and Alzheimer's disease: psychophysical and anatomic considerations. Ann N Y Acad Sci. 1991;540:20-27.
30. Fallon JH, Moore RY. Catecholamine innervation of the basal forebrain, III: olfactory bulb, anterior olfactory nuclei, olfactory tubercle and piriform cortex. J Comp Neurol. 1978;180:533-544.
31. Simpson MDC, Yates CM, Gordon A, St Clair DM. Olfactory tubercle choline acetyltransferase activity in Alzheimer type dementia, Down's syndrome and Huntington's disease. J Neurol Neurosurg Psychiatry. 1984;47:1138-1139.
32. Heafield MT, Fearn S, Steventon GB, Waring RH, Williams AC, Sturman SG. Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease. Neurosci Lett. 1990;110:216-220.
33. Steventon GB, Heafield MT, Waring RH, Williams AC. Xenobiotic metabolism in Parkinson's disease. Neurology. 1989;39:883-887.
34. Steventon GB, Heafield MT, Sturman S, Waring RH, Williams AC. Xenobiotic metabolism in Alzheimer's disease. Neurology. 1990;40:1095-1098.
35. Steventon GB, Heafield MT, Waring RH, Williams AC, Sturman S, Green M. Metabolism of low-dose paracetamol in patients with chronic neurological disease. Xenobiotica. 1990;20:117-122.
36. Bogerts B, Hantsch J, Herzer M. A morphometic study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics. Biol Psychiatry. 1983;18:951-969.
37. Rinne JO, Sako E, Paljarvi L, Molsa PK, Rinne UK. Brain dopamine D-1 receptors in senile dementia. J Neurol Sci. 1986;73:219-230.
38. Rinne JO, Sako E, Paljarvi L, Molsa PK, Rinne UK. Brain dopamine D-2 receptors in senile dementia. J Neural Transm. 1986;65:51-62.
39. Averback P. Two lesions in Alzheimer's disease. Lancet. 1983;2:1203.
40. Nordin S, Murphy C. Impaired sensory and cognitive olfactory function in questionable Alzheimer's disease. Neuropsychology. 1996;10:113-119.
41. Serby M, Mohan C, Aryan M, Williams L, Mohs RC, Davis KL. Olfactory identification deficits in relatives of Alzheimer's disease patients. Biol Psychiatry. 1996;39:375-377.
42. Moberg PJ, Doty RL. Olfactory function in Huntington's disease patients and atrisk offspring. Int J Neurosci. 1997;89:133-139.
43. Bylsma FW, Moberg PJ, Doty RL, Brandt J. Odor identification in Huntington's disease patients and asymptomatic gene carriers. J Neuropsychiatry Clin Neurosci. In press.
44. Noguchi S, Murakami K, Yamada N. Apolipoprotein E genotype and Alzheimer's disease. Lancet. 1993;342:737.
45. Poirier J, Davignon JOB, Kogan SPB, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 1993;342:697-699.
46. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron. 1993;11:575-580.
47. Saunders AM, Strittmatter WJ, St George-Hyslop PH, et al. Association of apolipoprotein F allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1467-1472.
48. Strittmatter WJ, Saunders AM, Schechel D, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci U S A. 1993;90:1977-1981.
49. Doty RL, Bromley SM, Stern MB. Olfactory testing as an aid in the diagnosis of Parkinson's disease: development of optimal discrimination criteria. Neurodegeneration. 1995;4:93-97.
50. Quinn NP, Rossor MN, Marsden CD. Olfactory threshold in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1987;50:88-89.
51. Stern MB, Doty RL, Dotti M, et al. Olfactory function in Parkinson's disease subtypes. Neurology. 1994;44:266-268.
52. Schiffman SS. Taste and smell in disease. N Engl J Med. 1983;308:1275-1279.
53. Van Toller C, Dodd GH, Billing A. Ageing and the Sense of Smell. Springfield, III: Charles C Thomas Publisher; 1985.
54. Bouloux PM, Munroe P, Kirk J, Besser GM. Sex and smell: an enigma resolved. J Endocrinol. 1992;133:323-326.
55. Corwin J, Loury M, Gilbert AN, Workplace, age, and sex as mediators of olfactory function: data from the National Geographic smell survey. J Gerontol Psychol Sci. 1995;50:P179-P186.
56. Doty RL, Shaman P, Applebaum RG, Siksorski L, Rosenberg L. Smell identification ability: changes with age. Science. 1984;226:1441-1443.
57. Ship JA, Weiffenback JM. Age, gender, medical treatment, and medication effects on smell identification. J Gerontol. 1993;48:M26-M32.
58. Kesslak JP, Nalcioglu O, Cotman CW. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology. 1991;41:51-54.
59. Kesslak JP, Cotman CW, Chui HC, et al. Olfactory tests as possible probes for detecting and monitoring Alzheimer's disease. Neurobiol Aging. 1988;9:399-403.
60. Koss E, Weiffenbach JM, Haxby JV, Friedland RP. Olfactory detection and identification performance are dissociated in early Alzheimer's disease. Neurology. 1988;38:1228-1232.
61. Morgan CD, Nordin S, Murphy C. Odor identification as an early marker for Alzheimer's disease: impact of lexical functioning and detection sensitivity. J Clin Exp Neuropsychol. 1995;17:793-803.
62. Rezek DL. Olfactory deficits as a neurologic sign in dementia of the Alzheimer type. Arch Neurol. 1987;44:1030-1032.
63. Serby M, Larson P, Kalkstein DS. The nature and course of olfactory deficits in Alzheimer's disease. Am J Psychiatry. 1991;148:357-360.
64. Warner MD, Peabody CA, Flattery JJ, Tinklenberg JR. Olfactory deficits in Alzheimer's disease. Biol Psychiatry. 1986;21:116-118.
65. Barz S, Hummel T, Pauli E, Majer M, Lang CJG, Kobal G. Chemosensory event-related potentials in response to trigeminal and olfactory stimulation in Parkinson's disease: investigations in patients and healthy controls on effects of anti-Parkinson drugs. Neurology. In press.
66. Busenbark KL, Huber SJ, Greer G, Pahwa R, Koller WC. Olfactory function in essential tremor. Neurology. 1992;42:1631-1632.
67. Doty RL, Singh A, Tetrud JT, Langston JW. Lack of major olfactory dysfunction in MPTP-induced Parkinsonism. Ann Neurol. 1992;32:97-100.
68. Wenning GK, Shephard B, Hawkes C, Petruckevitch A, Lees A, Quinn N. Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand. 1995;91:247-250.
69. Zucco GM, Zaglis D, Wambsganss CS. Olfactory deficits in elderly subjects and Parkinson patients. Percept Mot Skills. 1991;73:895-898.
70. Buchsbaum MS, Kesslak JP, Lynch G, Chui H. Temporal and hippocampal metabolic rate during an olfactory memory task assessed by positron emission tomography in patients with dementia of the Alzheimer type and controls: preliminary studies. Arch Gen Psychiatry. 1991;48:840-847.
71. Corwin J, Serby M, Conrad P, Rotrosen J. Olfactory recognition deficit in Alzheimer's and parkinsonian dementias. IRCS Med Sci Psychol Psychiatry. 1985;13:260.
72. Koss E. Olfactory dysfunction in Alzheimer's disease. Dev Neuropsychol. 1986;2:89-99.
73. Feldman JI, Murphy C, Davidson TM, Jalowayski AA, de Jaime GG. The rhinologic evaluation of Alzheimer's disease. Laryngoscope. 1991;101:1198-1202.
74. Murphy C, Gilmore MM, Seery CS, Salmon DP, Lasker BR. Olfactory thresholds are associated with degree of dementia in Alzheimer's disease. Neurobiol Aging. 1990;11:465-469.
75. Nordin S, Monsch AU, Murphy C. Unawareness of smell loss in normal aging and Alzheimer's disease: discrepancy between self-reported and diagnosed smell sensitivity. J Gerontol Psychol Sci. 1995;50B:P187-192.
76. Murofushi T, Mizuno M, Osanai R, Hayashida T. Olfactory dysfunction in Parkinson's disease. ORL J Otorhinolaryngol Relat Spec. 1991;53:143-146.